​
​

Keros Therapeutics (KROS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Keros Therapeutics Revenue Highlights

Latest Revenue (Y)

$151.00K

Latest Revenue (Q)

$37.00K

Main Segment (Y)

License

Keros Therapeutics Revenue by Period

Keros Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$151.00K100.00%
2022-12-31--100.00%
2021-12-31$20.10M100.00%
2020-12-31--100.00%
2019-12-31$10.00M-
2018-12-31$10.00M-

Keros Therapeutics generated $151.00K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 1.51% compared to the same period a year ago.

Keros Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$37.00K-55.42%
2024-03-31$83.00K-41.96%
2023-12-31$143.00K1687.50%
2023-09-30$8.00K100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30--100.00%
2022-06-30$100.00K100.00%
2022-03-31--100.00%
2021-12-31$20.00M100.00%
2021-09-30--100.00%
2021-06-30$100.00K100.00%
2021-03-31-100.00%
2020-12-31--100.00%
2020-09-30$2.50M-
2020-06-30$2.50M-
2020-03-31$2.50M-
2019-12-31$2.50M-
2019-09-30$2.50M-
2019-06-30$2.50M-
2019-03-31$2.50M-

Keros Therapeutics generated $37.00K in revenue during Q2 2024, up -55.42% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Keros Therapeutics Revenue Breakdown

Keros Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21
License$144.00M$144.00M

Keros Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 22: License (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Jun 23Mar 23Sep 22Jun 22Mar 22Dec 21Sep 21
Service$400.00K--------
Service, Other-$83.00K-------
License--$144.00M$144.00M$144.00M$144.00M$18.00M$20.00M$100.00K

Keros Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Service (100.00%).

Keros Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HRMYHarmony Biosciences$582.02M$186.04M
IDYAIDEAYA Biosciences$23.39M-
FENCFennec Pharmaceuticals$21.64M$6.97M
ANABAnaptysBio$17.16M$30.02M
MGTXMeiraGTx$14.02M$10.91M
JANXJanux Therapeutics$8.08M$8.90M
BOLTBolt Biotherapeutics$7.88M$1.14M
KZRKezar Life Sciences$7.00M-
IPSCCentury Therapeutics$2.23M$791.00K
FIXXQ32 Bio$1.16M-
KROSKeros Therapeutics$151.00K$37.00K
AVTEAerovate Therapeutics--
NGMNGM Biopharmaceuticals-$165.00K
REPLReplimune Group--
ERASErasca--
SNDXSyndax Pharmaceuticals-$12.50M
MLYSMineralys Therapeutics--
LRMRLarimar Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
SRZNSurrozen--

KROS Revenue FAQ

What is Keros Therapeutics’s yearly revenue?

Keros Therapeutics's yearly revenue for 2023 was $151K, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021. KROS's yearly revenue for 2021 was $20.1M, representing an increase of 100.00% compared to 2020.

What is Keros Therapeutics’s quarterly revenue?

Keros Therapeutics's quarterly revenue for Q2 2024 was $37K, a -55.42% decrease from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $83K, a -41.96% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). KROS's quarterly revenue for Q4 2023 was $143K, a 1687.50% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Keros Therapeutics’s revenue growth rate?

Keros Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -99.25%, and for the last 5 years (2019-2023) was -98.49%.

What are Keros Therapeutics’s revenue streams?

Keros Therapeutics's revenue streams in c 22 are License

What is Keros Therapeutics’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Keros Therapeutics was License. This segment made a revenue of $144M, representing 100.00% of the company's total revenue.